Effect of calcium ionophore (A23187) on embryo development and its safety in PGT cycles
- PMID: 36686427
- PMCID: PMC9846205
- DOI: 10.3389/fendo.2022.979248
Effect of calcium ionophore (A23187) on embryo development and its safety in PGT cycles
Abstract
Background: Intracytoplasmic sperm injection (ICSI) has tremendous advantages for resolving the problem of male infertility. However, ICSI fertilization can fail in some patients because of various reasons, primarily because of the failure of oocyte activation. Oocytes have been activated using calcium ionophore (A23187) in previous clinical cases of ICSI fertilization failure. However, studies on the efficiency of calcium ionophore (A23187) activation, its effects on the developmental potential of embryos, and its effects on pregnancy outcomes after embryo transfer are relatively limited.
Methods: In this study, we investigated the safety and long-term efficacy of calcium ionophore (A23187) by analyzing its effects on fertilization, embryonic development, aneuploidy, and pregnancy outcomes in patients undergoing preimplantation genetic testing (PGT) cycles.
Results: Comparative analyses of the activation followed by PGT (A-PGT) and PGT groups revealed no significant differences between the oocyte cleavage rate and high-quality embryo rate (98.19% vs. 98.63% and 63.13% vs. 68.39%, respectively, p > 0.05). Although the blastocyst formation rate was significantly lower in the A-PGT group than that in the PGT group (52.22% vs. 59.90%, p < 0.05), no significant difference was observed in the blastocyst aneuploidy rates of the two groups (24.49% vs. 24.55%, p > 0.05). Furthermore, no significant differences were observed between the two groups in terms of the live birth rate (43.75% vs. 52.99%), week of delivery, and birth weight of the infants after transfer of euploid blastocysts (p > 0.05). Furthermore, the 2PN rate, oocyte cleavage rate, blastocyst formation rate, and live birth rate were found to be significantly lower in the A-ICSI group than those in the ICSI group (p < 0.01), but there was no significant difference between the two groups in the week of delivery and birth weight of live births (p > 0.05).
Discussion: These results suggest that the use of calcium ionophore (A23187) activation as an option in cases of ICSI fertilization failure does not affect the ploidy of developing blastocysts and has no significant effects on the week of delivery or birth weight after transfer. Thus, we provide a scientific basis for the clinical safety of oocyte activation using calcium ionophore (A23187).
Keywords: calcium ionophore (A23187); chromosome aneuploidy; embryo development potential; fertilization failure; pregnancy outcome.
Copyright © 2023 Zhang, Yao, Zhang, Hu, Yang, He, He, Fan, Bai and Sun.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Calcium Ionophore (A23187) Rescues the Activation of Unfertilized Oocytes After Intracytoplasmic Sperm Injection and Chromosome Analysis of Blastocyst After Activation.Front Endocrinol (Lausanne). 2021 Jul 15;12:692082. doi: 10.3389/fendo.2021.692082. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34335469 Free PMC article.
-
Artificial oocyte activation with Ca2+ ionophore improves reproductive outcomes in patients with fertilization failure and poor embryo development in previous ICSI cycles.Front Endocrinol (Lausanne). 2023 Aug 11;14:1244507. doi: 10.3389/fendo.2023.1244507. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37635975 Free PMC article.
-
Assisted oocyte activation does not overcome recurrent embryo developmental problems.Hum Reprod. 2023 May 2;38(5):872-885. doi: 10.1093/humrep/dead051. Hum Reprod. 2023. PMID: 36931261
-
Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.Cochrane Database Syst Rev. 2020 Sep 8;9(9):CD005291. doi: 10.1002/14651858.CD005291.pub3. Cochrane Database Syst Rev. 2020. PMID: 32898291 Free PMC article.
-
A systematic review and meta-analysis: clinical outcomes of recurrent pregnancy failure resulting from preimplantation genetic testing for aneuploidy.Front Endocrinol (Lausanne). 2023 Oct 2;14:1178294. doi: 10.3389/fendo.2023.1178294. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37850092 Free PMC article.
Cited by
-
Optimization of handmade cloning enhances pregnancy rates and live calf production in cattle.Sci Rep. 2025 Apr 29;15(1):15032. doi: 10.1038/s41598-025-96511-8. Sci Rep. 2025. PMID: 40301396 Free PMC article.
-
Exploring key embryonic developmental morphokinetic parameters that affect clinical outcomes during the PGT cycle using time-lapse monitoring systems.BMC Pregnancy Childbirth. 2024 Dec 28;24(1):870. doi: 10.1186/s12884-024-07080-z. BMC Pregnancy Childbirth. 2024. PMID: 39732641 Free PMC article.
-
Human oocyte zona pellucida abnormalities: evaluation of clinical impact for different zona pellucida abnormalities and role of using assisted hatching.J Assist Reprod Genet. 2025 Jan;42(1):303-317. doi: 10.1007/s10815-024-03306-3. Epub 2024 Nov 9. J Assist Reprod Genet. 2025. PMID: 39520601
-
Assessing the impact of calcium ionophore on pregnancy outcomes in artificial oocyte activation cycles: a 10-year update of systematic review and meta-analysis.J Assist Reprod Genet. 2025 Jan;42(1):165-183. doi: 10.1007/s10815-024-03319-y. Epub 2024 Nov 19. J Assist Reprod Genet. 2025. PMID: 39557784
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical